Myocardial Infarction as the First Manifestation of Coronary Heart Disease: Rates of Heralded and Unheralded Myocardial Infarction
NCT ID: NCT01168869
Last Updated: 2015-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
9000 participants
OBSERVATIONAL
2009-09-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study aims to quantify the proportion of MIs that occur 'unheralded' and also give an estimate of the incidence of 'unheralded' MI in the UK, compared to 'heralded' MI and those with angina of recent onset (MIs with premonitory symptoms).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Previous Cardiovascular Disease, Cardiovascular Risk Factors and Chest Pain in First Myocardial Infarction
NCT01379131
Gender Differences in the Development, Treatment and Prognosis of Coronary Disease: A CALIBER Study
NCT01164371
Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes
NCT01804439
Incidence of and Prognostic Factors Associated With Heart Failure Following Myocardial Infarction: a CALIBER Study
NCT02384213
Variation Between Hospitals in Short-term Mortality After Acute Coronary Syndromes: A CALIBER Study
NCT01111071
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Using data from MINAP and GPRD, patients experiencing their first myocardial infarction (MI) will be separated into three categories:
* 'Heralded MI': patients who have been diagnosed or treated for cardiovascular disease for more than 90 days before MI.
* 'MI with premonitory symptoms': patients who have been diagnosed or treated for cardiovascular disease within the 90 days prior to MI.
* 'Unheralded MI': patients without a cardiovascular disease diagnosis or treatment at any time before MI.
Patients with MI will be identified in the linked GPRD-MINAP record. Using GPRD population denominators, this study will establish the absolute incidence rates of first 'unheralded' MI by calendar year, age, sex, season, MI subtype (ST-elevation MI and non ST-elevation MI) and region and compare these to the rates of first 'heralded' MIs and first 'MI with premonitory symptoms'.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GPRD patients
All patients included in "up to standard" GPRD practices that agreed to the linkage with the MINAP database are included in this cohort.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age over 18.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
British Medical Research Council
OTHER_GOV
University College, London
OTHER
London School of Hygiene and Tropical Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emily Herrett
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily Herrett, MSc
Role: PRINCIPAL_INVESTIGATOR
London School of Hygiene and Tropical Medicine
Harry Hemingway, FRCP
Role: STUDY_DIRECTOR
University College, London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
London School of Hygiene and Tropical Medicine
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
086091/Z/08/Z
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CALIBER 09-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.